5 Key Takeaways
-
1
Endogenous fungal endophthalmitis accounts for 5% to 10% of endophthalmitis cases, with fungi and bacteria each representing about half.
-
2
Primary risk factors for endogenous fungal endophthalmitis include malignancy, intravenous drug use, and immunosuppression.
-
3
The 2016 IDSA guidelines recommend systemic fluconazole or voriconazole for all patients, with adjunctive intravitreal antifungals for severe cases.
-
4
In a multicenter study, 72% of eyes received combination systemic and intravitreal antifungals, with voriconazole and fluconazole being the most common agents.
-
5
Treatment strategies for endogenous fungal endophthalmitis vary regionally, with systemic culture positivity influencing the choice of initial therapy.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.